| Health / Medical Topics |
Linaprazan
A lipophilic, weak base with potassium-competitive acid blocking (P-CAB) activity. Linaprazan concentrates highly in the gastric parietal cell canaliculus and on entering this acidic environment is instantly protonated and binds competitively and reversibly to the potassium binding site of the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase), thereby inhibiting the pump's activity and the parietal cell secretion of H+ ions into the gastric lumen, the final step in gastric acid production. (NCI Thesaurus)
YOU MAY ALSO LIKE
A potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. The inhibition of DPP-4 by linagliptin appears to…
The acetate salt form of linaclotide, a synthetic, fourteen amino acid peptide and agonist of intestinal guanylate cyclase type C (GC-C), which…
A synthetic, fourteen amino acid peptide and agonist of intestinal guanylate cyclase type C (GC-C), which is structurally related to the guanylin…
A machine that uses electricity to form a stream of fast-moving subatomic particles. This creates high-energy radiation that may be used to…
Human LIN28B wild-type allele is located in the vicinity of 6q21 and is approximately 126 kb in length. This allele, which encodes…
This gene plays a role in the suppression of miRNA processing.
